Law360, New York (March 31, 2009) -- Life Technologies Corp. has struck a deal to resolve its infringement suit against General Electric Co. and several GE health care units over a patent covering DNA amplification kits; however, a separate Life Technologies suit against GE over six patents related to reverse transcriptase enzyme kits continues.
The Carlsbad, Calif.-based company, formerly known as Invitrogen Corp., and GE gave notice to the U.S. District Court for the Eastern District of Texas on Tuesday that they have settled...
